Sign Up to like & get
recommendations!
1
Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223211067631
Abstract: Background: For chronic hepatitis C (CHC) patients completing pegylated interferon (PegIFN)-α/ribavirin therapy, long-term liver histological changes remain largely unexplored. Methods: This observational cohort study included 85 CHC patients completing PegIFN-α/ribavirin therapy with liver biopsies performed…
read more here.
Keywords:
svr cases;
patients completing;
liver histological;
ribavirin therapy ... See more keywords